Your browser doesn't support javascript.
loading
InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions.
Bourdin, Arnaud; Criner, Gerard; Devouassoux, Gilles; Dransfield, Mark; Halpin, David M G; Han, MeiLan K; Jones, C Elaine; Kalhan, Ravi; Lange, Peter; Lettis, Sally; Lipson, David A; Lomas, David A; Echave-Sustaeta María-Tomé, José M; Martin, Neil; Martinez, Fernando J; Quasny, Holly; Sail, Lynda; Siler, Thomas M; Singh, Dave; Thomashow, Byron; Watz, Henrik; Wise, Robert; Hanania, Nicola A.
Afiliação
  • Bourdin A; Department of Pneumology and Addictology, University of Montpellier, CHU Montpellier, Montpellier, France.
  • Criner G; Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, United States.
  • Devouassoux G; Univ. Lyon, Université Claude-Bernard Lyon 1, Lyon, France.
  • Dransfield M; Hôpital de la Croix-Rousse, Service de Pneumologie, Hospices Civils de Lyon, Lyon, France.
  • Halpin DMG; Division of Pulmonary, Allergy, and Critical Care Medicine, Lung Health Center, University of Alabama at Birmingham, Birmingham, Alabama, United States.
  • Han MK; College of Medicine and Health, University of Exeter Medical School, University of Exeter, Exeter, United Kingdom.
  • Jones CE; Pulmonary and Critical Care, University of Michigan, Ann Arbor, Michigan, United States.
  • Kalhan R; GlaxoSmithKline, Research Triangle Park, North Carolina, United States.
  • Lange P; Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States.
  • Lettis S; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Lipson DA; Medical Department, Herlev University Hospital, Herlev, Denmark.
  • Lomas DA; GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex, United Kingdom.
  • Echave-Sustaeta María-Tomé JM; GlaxoSmithKline, Collegeville, Pennsylvania, United States.
  • Martin N; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
  • Martinez FJ; UCL Respiratory, University College London, London, United Kingdom.
  • Quasny H; Respiratory Department, Hospital Universitario Quirónsalud Madrid, Universidad Europea de Madrid, Madrid, Spain.
  • Sail L; GlaxoSmithKline, Brentford, Middlesex, United Kingdom.
  • Siler TM; University of Leicester, Leicester, United Kingdom.
  • Singh D; Weill Cornell Medicine, New York, New York, United States.
  • Thomashow B; GlaxoSmithKline, Research Triangle Park, North Carolina, United States.
  • Watz H; GlaxoSmithKline, Paris, France.
  • Wise R; Midwest Chest Consultants, PC, St Charles, Missouri, United States.
  • Hanania NA; The University of Manchester, Manchester University National Health Service Foundation Trust, United Kingdom.
Chronic Obstr Pulm Dis ; 8(1)2021 Jan.
Article em En | MEDLINE | ID: mdl-33156982
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article